HemaClear

Frequently Asked Questions

1. What`s the HemaClear® made of?
2. How does the HemaClear® work?
3. Does the material that the HemaClear® is made of add to its sterility?
4. How is the HemaClear® sterilized?
5. What is the shelf life of the HemaClear®?
6. What happens if the expiration date of the HemaClear® passes?
7. What are the clinical and financial benefits of the HemaClear®?
8. How long can the HemaClear® remain on the limb?
9. How much pressure is applied by the HemaClear®?
10. The HemaClear® applies a strong pressure in a small area. Can this not cause damage to the limb?
11. It is known that wider cuffs are better than narrow cuffs. The HemaClear® is ultra narrow. Does this present a problem?
1. What`s the HemaClear® made of?
The HemaClear® is made of silicone ring wrapped in a stockinet sleeve and 2 pull handles.
2. How does the HemaClear® work?
The surgeon places the HemaClear® silicon ring on the patient`s fingers or toes and then pulls the handles proximally. The ring rolls up the limb and the stockinet sleeve unfolds. During the rolling up the limb, the ring exerts pressure and squeezes the blood away from the limb, performing the exsanguinating (blood removal) function quickly and effectively.

When the ring reaches the occlusion site, the pulling motion is stopped. The ring exerts pressure on the limb at this position, blocking arterial blood flow into the limb and performing the occlusion function.

During the motion over the limb, the stockinet sleeve unfolds onto the limb, covering it entirely up to the occlusion level providing a sterile cover of the surgical field. The entire motion on the limb from fingers or toes to the occlusion location, takes less than 12 seconds. *

* de Kiewiet G P. Moving to a new type of sterile and single use tourniquet for orthopaedic surgery. Orthopaedic Product News 2006 March/April; 44-48
3. Does the material that the HemaClear® is made of add to its sterility?
No. The components of the HemaClear® (silicon ring, stockinet and pull straps) arrive at OHK factory in Israel non sterile. After the device is assembled it is sent as a complete unit for sterilization.
4. How is the HemaClear® sterilized?
The HemaClear® is sterilized by Ethylene Oxide (ETO).
5. What is the shelf life of the HemaClear®?
3 years.
6. What happens if the expiration date of the HemaClear® passes?
Do not use the HemaClear® if the expiration date passed. After 3 years the sterility of the device might be damaged.
7. What are the clinical and financial benefits of the HemaClear®?
The HemaClear ® is superior to the current exsanguination and occlusion solutions and offers both clinical and financial advantages:
1. All in one solution - The HemaClear® performs exsanguination, occlusion and sterile field covering in one simple and quick application.
2. Clear visibility - up to 95% exsanguination compared to 65% with the current techniques, reducing the amount of stagnant intra vascular blood left behind to clot.
3. Saves up to 15 Minutes of Prep and Surgery time and cuts down up to 80 pre and intra-operative steps in a typical case from the overall procedure processes.
4. Sterile Single Use device assisting in the prevention of surgical site infections.
5. Factory calibrated – The HemaClear® provides consistent pressure with no reported case of tourniquet paralysis (compared with incidence of 1:4200 using the pneumatic tourniquet).
6. Reduces the volume of ischemic tissue. The HemaClear® can be placed closer to the surgical field (e.g. forearm for hand surgery, instead of upper arm; calf instead of thigh for foot and ankle procedures) thereby reducing the amount of tissue under ischemic condition.
7. Full Range of sizes from pediatric to obese; Narrow design allows more operating space on appendages and better patient comfort.
8. The HemaClear® reduces the amount of blood loss during surgery thus reducing the
need for blood transfusions and blood disposal.*

* Henderson M S. Exsanguinating tourniquet Assessed. Clinical Services Journal 2006 Sept; 81-84.
8. How long can the HemaClear® remain on the limb?
As with any other tourniquet, the HemaClear® can remain on the limb for up to 2 hours. If a procedure lasts longer than two hours the HemaClear® should be removed by safely cutting the ring. After a proper duration of blood flow resumption a second HemaClear® can be applied. The HemaClear® can safely be passed over the surgical incision as it is a sterile device.
9. How much pressure is applied by the HemaClear®?
The pressure applied by the HemaClear® ring on the limb is dependent on the circumference of the limb at the occlusion location and the distance from there to the tips of the fingers or toes. It is also dependent on the model (color) of the HemaClear® used. The ranges of pressure are:*

* Levenberg E. S-MART® and A-TT® ring pressure analysis: Finite element analysis of pressure and displacement inside a limb compressed by a circular ring.
10. The HemaClear® applies a strong pressure in a small area. Can this not cause damage to the limb?
Over 70,000 HemaClear units have been sold and there have been no reports of tissue damage following use of the HemaClear®. The pressure developed inside the limb from the HemaClear® is equivalent to the pressure developed by the pneumatic tourniquet. Therefore, pressure occlusion levels that have been determined to be safe with conventional tourniquet cuffs are also safe with the HemaClear®.
11. It is known that wider cuffs are better than narrow cuffs. The HemaClear® is ultra narrow. Does this present a problem?
To stop blood flow, it is sufficient to occlude the artery over a venues short segment, which is efficiently achieved by the HemaClear®. Compressing a much larger volume of tissue is not necessary and may actually be detrimental. The lower pressure needed to occlude blood flow with a wide cuff, relative to a narrow one, does not balance out the more external tissue compression. Furthermore, the wide cuff elongates the nerves which may cause telescoping and damage.*

* Mittal P. et al. Effect of different cuff widths on the motor nerve conduction of the median nerve: an experimental study. Journal of Orthopedic Surgery and Research 2008; 9:3(1).